ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma Multiforme

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01435395
Recruitment Status : Completed
First Posted : September 16, 2011
Last Update Posted : April 27, 2016
Sponsor:
Collaborators:
Schering-Plough
Genentech, Inc.
Millennium Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Jeffrey James Olson, Emory University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2016
  Actual Study Completion Date : April 2016